Back
ADMA Biologics Vs. Corcept Therapeutics Industry Stock Comparison
Buy
72
ADMA
ADMA Biologics
Last Price:
20.21
Seasonality Move:
3.76%
Buy
75
CORT
Corcept Therapeutics
Last Price:
54.76
Seasonality Move:
4.71%
Buy
72
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
- The current ADMA Biologics [ADMA] share price is $20.20. The Score for ADMA is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ADMA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $54.79. The Score for CORT is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $20.20
The current trend is moderately bullish and ADMA is experiencing selling pressure, which indicates risk of future bearish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $54.79
The current trend is moderately bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
ADMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.01 | Buy |
| Relative Strength Index (14 RSI): | 56.87 | Buy |
| Chaikin Money Flow: | -3091216 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.71 - 20.27) | Buy |
| Bollinger Bands (100): | (13.13 - 19.45) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.25 | Buy |
| Relative Strength Index (14 RSI): | 61.59 | Buy |
| Chaikin Money Flow: | -660476 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.05 - 54.67) | Buy |
| Bollinger Bands (100): | (32.18 - 47.4) | Buy |
ADMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.85 | Sell |
| 20-day SMA: | 18.31 | Buy |
| 50-day SMA: | 18.5 | Buy |
| 200-day SMA: | 11.74 | Buy |
| 8-day EMA: | 20.6 | Sell |
| 20-day EMA: | 19.37 | Buy |
| 50-day EMA: | 18.17 | Buy |
| 200-day EMA: | 13.05 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.05 | Sell |
| 20-day SMA: | 51.44 | Buy |
| 50-day SMA: | 45.85 | Buy |
| 200-day SMA: | 32.7 | Buy |
| 8-day EMA: | 55.3 | Sell |
| 20-day EMA: | 52.15 | Buy |
| 50-day EMA: | 46.92 | Buy |
| 200-day EMA: | 36.16 | Buy |
ADMA Biologics Earnings Growth & ADMA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.22 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
ADMA Biologics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||